CHOROIDEREMIA

Clinical trials for CHOROIDEREMIA explained in plain language.

Never miss a new study

Get alerted when new CHOROIDEREMIA trials appear

Sign up with your email to follow new studies for CHOROIDEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New eye injection shows promise for rare vision loss diseases

Disease control Completed

This study tested a new drug called KIO-301, given as an injection into the eye, for people with two rare eye diseases that cause vision loss: retinitis pigmentosa and choroideremia. The goal was to check if the drug is safe and if it can help improve vision. The study included 3…

Matched conditions: CHOROIDEREMIA

Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 09, 2026 05:20 UTC

CHOROIDEREMIA

Get alerted when new CHOROIDEREMIA trials appear

New eye injection shows promise for rare vision loss diseases